PathoQuest Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 33
Employees
  • Latest Deal Type
  • Series B
  • (Upcoming)
  • Latest Deal Amount
  • $15M
Latest Deal Amount
  • Investors
  • 5

PathoQuest General Information

Description

Developer of a molecular diagnostics technology designed to improve pathogen detection in biological samples. The company's technology combines sample preparation technology and cloud-based bioinformatics which is applicable to several types of samples with a proprietary pathogen genome sequence database and automated analysis pipeline, enabling doctors to improve the breadth of pathogen detection.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Primary Office
  • BioPark - Bâtiment B
  • 11 rue Watt
  • 75013 Paris
  • France
+33 01 00 00 00 00

PathoQuest Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PathoQuest Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) $15M Upcoming Generating Revenue
7. Early Stage VC 29-Dec-2020 00.000 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series A) 05-Sep-2019 00.000 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series A) 14-Jun-2018 00.000 000.00 000.00 Completed Generating Revenue
4. Later Stage VC 01-Jan-2018 00.00 Completed Generating Revenue
3. Later Stage VC 15-Jun-2017 00.000 00.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Jul-2013 $5.02M $5.26M 00.000 Completed Startup
1. Early Stage VC (Series A) 11-Mar-2011 $2.75M $2.75M 00.000 Completed Startup
To view PathoQuest’s complete valuation and funding history, request access »

PathoQuest Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P2 Shares 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
P2 Shares 00,000 00.000000 000.00 000.00 00 000.00 00.000
P2 Shares 00,000 00.000000 000.00 000.00 00 000.00 0.000
P Shares 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
P Shares 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
P Shares 21,738 $1.214633 $212.83 $212.83 1x $212.83 6.74%
P Shares 14,914 $1.214633 $121.46 $121.46 1x $121.46 4.62%
To view PathoQuest’s complete cap table history, request access »

PathoQuest Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a molecular diagnostics technology designed to improve pathogen detection in biological samples. The compan
Biotechnology
Paris, France
33 As of 2021
000.00
000000 0

000000 0

oris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
0000 000000000
Brisbane, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

0000000

on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit i
0000 000000000
Cambridge, MA
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PathoQuest Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Second Genome Venture Capital-Backed Brisbane, CA 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Cambridge, MA 000 00000 00000000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

PathoQuest Executive Team (14)

Name Title Board Seat Contact Info
Jean-François Brepson President & Chief Executive Officer
Eric Cazergue Chief Financial Officer
Patrick Court Chief Financial Officer
Laurent Lafferrère Ph.D Chief Operating Officer
Stéphane Cruveiller Ph.D Chief Technology Information Officer
You’re viewing 5 of 14 executive team members. Get the full list »

PathoQuest Board Members (6)

Name Representing Role Since
Benedikt von Braunmühl Self Chairman 000 0000
Bernard Courtieu MD Self Board Member 000 0000
Christiane Honisch Ph.D Self Board Member 000 0000
Jean-Pascal Beaufret Aurinvest Board Member 000 0000
Thierry Laugel Ph.D Kurma Partners Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

PathoQuest Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PathoQuest Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Verve Ventures Venture Capital Minority 000 0000 000000 0
Charles River Laboratories Corporation Minority 000 0000 000000 0
Aurinvest Venture Capital Minority 000 0000 000000 0
Idinvest Partners PE/Buyout Minority 000 0000 000000 0
Kurma Partners Venture Capital Minority 000 0000 000000 0
To view PathoQuest’s complete investors history, request access »